ArticleInvestigational new drugs2010

Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines.

D M Collins et al.PubMed ↗Publisher ↗

No numbers read from the abstract.